High-pro­file Chi­nese in­vestor Vin­cent Che­ung plays a lead role in rais­ing $100M round for a Boston start-up

Vin­cent Che­ung, the high-pro­file ven­ture in­vestor at Nan Fung Tech­nol­o­gy’s Piv­otal Be­ta, took a lead­ing role in putting to­geth­er a mega-round of $100 mil­lion for a biotech up­start called Stealth Bio­Ther­a­peu­tics. 

Stealth CEO Ree­nie Mc­Carthy says they’ll use the cash to pay for a Phase IIb study of their drug elamipre­tide for age-re­lat­ed mac­u­lar de­gen­er­a­tion as they push through a piv­otal tri­al for mi­to­chon­dr­i­al my­opa­thy and a Phase II/III clin­i­cal tri­al in Barth syn­drome.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER